Page 0039

RESEARCH AND DEVELOPMENT

39 CANCER CONTROL 2021

registries that can provide a continuous stream of highquality data in most countries. This would imply availability

of adequate resources to register all patients with cancer

in a timely fashion, the right to access up-to-date national

or regional death records to establish their vital status, the

legislative stability to operate efficiently over the long term,

and the autonomy to deploy all their data for research. n

Acknowledgements

I would like to thank Pamela Minicozzi and Veronica Di Carlo for

their help in analysing the questionnaires and preparing the figures.

Professor Claudia Allemani is Professor of Global Public Health

at LSHTM. Her main interests are in international comparisons of

cancer survival, "high-resolution" studies on patterns of care, as

well as the estimation of avoidable premature deaths, with a focus

on their impact on cancer policy. She has 20 years' experience in

this domain. She is co-Principal Investigator of the CONCORD

programme for the global surveillance of cancer survival and

Principal Investigator of VENUSCANCER.

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:

sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136:

E359-86.

2. Ginsburg O, Bray F, Coleman MP, et al. The global burden of women's cancers: a grand

challenge in global health [Lancet Series on Women's Cancers]. Lancet 2017; 389: 847-

60.

3. Coleman MP. Cancer survival: global surveillance will stimulate health policy and

improve equity. Lancet 2014; 383: 564-73.

4. Meara JG, Leather AJM, Hagander L, et al. Global Surgery 2030: evidence and solutions

for achieving health, welfare, and economic development. Lancet 2015; 386: 569-624.

5. International Atomic Energy Agency. Inequity in cancer care: a global perspective. IAEA

Human Health Reports No. 3. Vienna: IAEA, 2011.

6. Atun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet

Oncol 2015; 16: 1153-86.

7. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival

2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients

diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Lancet 2018; 391: 1023-75.

8. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark,

Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership):

an analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.

9. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income

countries. Lancet Oncol 2011; 12: 933-80.

10. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-

2009: analysis of individual data for 25,676,887 patients from 279 population-based

registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010.

References

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066